SymBio PharmaceuticalsCompany research
Click on headlines below to download research
Top-line data from registrational DLBCL study
SymBio Pharmaceuticals | 28/05/2020
SymBio will be presenting data at the European Society of Hematology (EHA) meeting from its pivotal study in Japan of Treakisym (bendamustine) in combination…
Top-line data from registrational DLBCL study
SymBio Pharmaceuticals | 26/05/2020
SymBio will be presenting data at the European Society of Hematology (EHA) meeting from its pivotal study in Japan of Treakisym (bendamustine) in combination…
Treakisym label expansion submitted
SymBio Pharmaceuticals | 22/05/2020
SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed and refractory…